mirror of
https://github.com/soapingtime/diyhrt.git
synced 2026-03-23 07:36:38 +00:00
[automated] update transfemscience
This commit is contained in:
parent
2b3a11c913
commit
0a1ecd2872
6 changed files with 20 additions and 9 deletions
File diff suppressed because one or more lines are too long
File diff suppressed because one or more lines are too long
File diff suppressed because one or more lines are too long
|
|
@ -1 +1 @@
|
|||
<?xml version="1.0" encoding="utf-8"?><feed xmlns="http://www.w3.org/2005/Atom" ><generator uri="https://jekyllrb.com/" version="3.9.5">Jekyll</generator><link href="https://transfemscience.org/feed-posts.xml" rel="self" type="application/atom+xml" /><link href="https://transfemscience.org/" rel="alternate" type="text/html" /><updated>2024-07-01T12:20:48-07:00</updated><id>https://transfemscience.org/feed-posts.xml</id><title type="html">Transfeminine Science</title><subtitle>Transfeminine Science is a site for information on hormone therapy for transfeminine people.</subtitle><author><name>Transfeminine Science</name></author></feed>
|
||||
<?xml version="1.0" encoding="utf-8"?><feed xmlns="http://www.w3.org/2005/Atom" ><generator uri="https://jekyllrb.com/" version="3.10.0">Jekyll</generator><link href="https://transfemscience.org/feed-posts.xml" rel="self" type="application/atom+xml" /><link href="https://transfemscience.org/" rel="alternate" type="text/html" /><updated>2024-11-17T23:59:50-08:00</updated><id>https://transfemscience.org/feed-posts.xml</id><title type="html">Transfeminine Science</title><subtitle>Transfeminine Science is a site for information on hormone therapy for transfeminine people.</subtitle><author><name>Transfeminine Science</name></author></feed>
|
||||
|
|
@ -1,4 +1,4 @@
|
|||
<?xml version="1.0" encoding="utf-8"?><feed xmlns="http://www.w3.org/2005/Atom" ><generator uri="https://jekyllrb.com/" version="3.9.5">Jekyll</generator><link href="https://transfemscience.org/feed.xml" rel="self" type="application/atom+xml" /><link href="https://transfemscience.org/" rel="alternate" type="text/html" /><updated>2024-07-01T12:20:48-07:00</updated><id>https://transfemscience.org/feed.xml</id><title type="html">Transfeminine Science | Articles</title><subtitle>Transfeminine Science is a site for information on hormone therapy for transfeminine people.</subtitle><author><name>Transfeminine Science</name></author><entry><title type="html">Puberty Blockers: A Review of GnRH Analogues in Transgender Youth</title><link href="https://transfemscience.org/articles/puberty-blockers/" rel="alternate" type="text/html" title="Puberty Blockers: A Review of GnRH Analogues in Transgender Youth" /><published>2022-01-30T15:04:00-08:00</published><updated>2022-01-31T00:00:00-08:00</updated><id>https://transfemscience.org/articles/puberty-blockers</id><content type="html" xml:base="https://transfemscience.org/articles/puberty-blockers/"><![CDATA[<h1 id="puberty-blockers-a-review-of-gnrh-analogues-in-transgender-youth">Puberty Blockers: A Review of GnRH Analogues in Transgender Youth</h1>
|
||||
<?xml version="1.0" encoding="utf-8"?><feed xmlns="http://www.w3.org/2005/Atom" ><generator uri="https://jekyllrb.com/" version="3.10.0">Jekyll</generator><link href="https://transfemscience.org/feed.xml" rel="self" type="application/atom+xml" /><link href="https://transfemscience.org/" rel="alternate" type="text/html" /><updated>2024-11-17T23:59:50-08:00</updated><id>https://transfemscience.org/feed.xml</id><title type="html">Transfeminine Science | Articles</title><subtitle>Transfeminine Science is a site for information on hormone therapy for transfeminine people.</subtitle><author><name>Transfeminine Science</name></author><entry><title type="html">Puberty Blockers: A Review of GnRH Analogues in Transgender Youth</title><link href="https://transfemscience.org/articles/puberty-blockers/" rel="alternate" type="text/html" title="Puberty Blockers: A Review of GnRH Analogues in Transgender Youth" /><published>2022-01-30T15:04:00-08:00</published><updated>2022-01-31T00:00:00-08:00</updated><id>https://transfemscience.org/articles/puberty-blockers</id><content type="html" xml:base="https://transfemscience.org/articles/puberty-blockers/"><![CDATA[<h1 id="puberty-blockers-a-review-of-gnrh-analogues-in-transgender-youth">Puberty Blockers: A Review of GnRH Analogues in Transgender Youth</h1>
|
||||
|
||||
<!-- Supports up to four authors per article currently (author, author2, author3, author4) -->
|
||||
|
||||
|
|
@ -2509,13 +2509,13 @@ Using the term desistence in this way does not imply anything about the identity
|
|||
<li>Wren, B. G., Day, R. O., McLachlan, A. J., & Williams, K. M. (2003). Pharmacokinetics of estradiol, progesterone, testosterone and dehydroepiandrosterone after transbuccal administration to postmenopausal women. <em>Climacteric</em>, <em>6</em>(2), 104–111. [DOI:<a href="https://doi.org/10.1080/cmt.6.2.104.111">10.1080/cmt.6.2.104.111</a>]</li>
|
||||
<li>Yaish, I., Gindis, G., Greenman, Y., Moshe, Y., Arbiv, M., Buch, A., Sofer, Y., Shefer, G., & Tordjman, K. (2023). Sublingual Estradiol Offers No Apparent Advantage Over Combined Oral Estradiol and Cyproterone Acetate for Gender-Affirming Hormone Therapy of Treatment-Naive Trans Women: Results of a Prospective Pilot Study. <em>Transgender Health</em>, <em>8</em>(6), 485–493. [DOI:<a href="https://doi.org/10.1089/trgh.2023.0022">10.1089/trgh.2023.0022</a>]</li>
|
||||
<li>Yaish, I., Gindis, G., Greenman, Y., Shefer, G., Buch, A., Arbiv, M., Moshe, Y., Sofer, Y., & Tordjman, K. M. (2023). Sublingual Estradiol Only, Compared To Combined Oral Estradiol And Cyproterone Acetate,Offers No Apparent Advantage For Gender Affirming Hormone Therapy (GHAT), In Treatment Naïve Transwomen: Results Of A Prospective Pilot Study. <em>Journal of the Endocrine Society</em>, <em>7</em>(Suppl 1) [<em>ENDO 2023 Abstracts Annual Meeting of the Endocrine Society</em>], A1104–A1105 (abstract no. SAT409/bvad114.2080). [DOI:<a href="https://doi.org/10.1210/jendso/bvad114.2080">10.1210/jendso/bvad114.2080</a>] [<a href="https://academic.oup.com/jes/article-pdf/7/Supplement_1/bvad114.2080/51899408/bvad114.2080.pdf">PDF</a>]</li>
|
||||
</ul>]]></content><author><name>{"first_name"=>"Sam", "last_name"=>"S.", "author-link"=>"/about/#sam", "articles-link"=>"/articles-by-author/sam/"}</name></author><category term="github" /><category term="workspace" /><summary type="html"><![CDATA[An Exploration of Sublingual Estradiol as an Alternative to Oral Estradiol in Transfeminine People By Sam | First published June 11, 2021 | Last modified March 30, 2024]]></summary></entry><entry><title type="html">Clinical Guidelines with Information on Transfeminine Hormone Therapy</title><link href="https://transfemscience.org/articles/transfem-hormone-guidelines/" rel="alternate" type="text/html" title="Clinical Guidelines with Information on Transfeminine Hormone Therapy" /><published>2020-11-20T10:00:00-08:00</published><updated>2024-06-26T00:00:00-07:00</updated><id>https://transfemscience.org/articles/transfem-hormone-guidelines</id><content type="html" xml:base="https://transfemscience.org/articles/transfem-hormone-guidelines/"><![CDATA[<h1 id="clinical-guidelines-with-information-on-transfeminine-hormone-therapy">Clinical Guidelines with Information on Transfeminine Hormone Therapy</h1>
|
||||
</ul>]]></content><author><name>{"first_name"=>"Sam", "last_name"=>"S.", "author-link"=>"/about/#sam", "articles-link"=>"/articles-by-author/sam/"}</name></author><category term="github" /><category term="workspace" /><summary type="html"><![CDATA[An Exploration of Sublingual Estradiol as an Alternative to Oral Estradiol in Transfeminine People By Sam | First published June 11, 2021 | Last modified March 30, 2024]]></summary></entry><entry><title type="html">Clinical Guidelines with Information on Transfeminine Hormone Therapy</title><link href="https://transfemscience.org/articles/transfem-hormone-guidelines/" rel="alternate" type="text/html" title="Clinical Guidelines with Information on Transfeminine Hormone Therapy" /><published>2020-11-20T10:00:00-08:00</published><updated>2024-11-17T00:00:00-08:00</updated><id>https://transfemscience.org/articles/transfem-hormone-guidelines</id><content type="html" xml:base="https://transfemscience.org/articles/transfem-hormone-guidelines/"><![CDATA[<h1 id="clinical-guidelines-with-information-on-transfeminine-hormone-therapy">Clinical Guidelines with Information on Transfeminine Hormone Therapy</h1>
|
||||
|
||||
<!-- Supports up to four authors per article currently (author, author2, author3, author4) -->
|
||||
|
||||
<p>By
|
||||
<!-- First author --><a href="/about/#aly">Aly</a><!-- Second author --><!-- Third author --><!-- Fourth author --> | First published November 20, 2020
|
||||
| Last modified June 26, 2024</p>
|
||||
| Last modified November 17, 2024</p>
|
||||
|
||||
<h2 id="abstract--tldr">Abstract / TL;DR</h2>
|
||||
|
||||
|
|
@ -2796,6 +2796,12 @@ Using the term desistence in this way does not imply anything about the identity
|
|||
<td>2018</td>
|
||||
<td>Published article</td>
|
||||
</tr>
|
||||
<tr>
|
||||
<td><a href="https://patha.nz/Guidelines">Primary Care Gender Affirming Hormone Therapy Initiation Guidelines: Aotearoa New Zealand Guidelines for Commencing GAHT for Adults in Primary Care</a> [<a href="https://patha.nz/resources/Documents/Primary-Care-GAHT-Guidelines_Web_29-Mar.pdf">PDF</a>]</td>
|
||||
<td>Carroll et al. / PATHA / University of Otago</td>
|
||||
<td>2023</td>
|
||||
<td>Online document</td>
|
||||
</tr>
|
||||
</tbody>
|
||||
</table>
|
||||
|
||||
|
|
@ -2865,6 +2871,10 @@ Using the term desistence in this way does not imply anything about the identity
|
|||
</tbody>
|
||||
</table>
|
||||
|
||||
<h2 id="update-new-endocrine-society-and-ucsf-guidelines">Update: New Endocrine Society and UCSF Guidelines</h2>
|
||||
|
||||
<p>New Endocrine Society and UCSF guidelines are under development as of February 2024 (<a href="https://www.cnn.com/2024/02/26/health/endocrine-society-gender-affirming-care-guidelines/index.html">Christensen, 2024</a>; <a href="https://www.endocrine.org/clinical-practice-guidelines/guidelines-in-development">Endocrine Society, 2024</a>; <a href="https://transcare.ucsf.edu/guidelines">UCSF, 2024</a>). It is anticipated that the Endocrine Society guidelines will be published in Spring 2026. The new UCSF guidelines were initially slated for publication in 2024, but have been pushed back until the new Endocrine Society guidelines are published. The new Endocrine Society and UCSF guidelines will be the third edition of each of the guidelines.</p>
|
||||
|
||||
<h2 id="references">References</h2>
|
||||
|
||||
<ul>
|
||||
|
|
@ -2873,6 +2883,7 @@ Using the term desistence in this way does not imply anything about the identity
|
|||
<li>Bewley, S., Dahlen, S., Connolly, D., Arif, I., Junejo, M., & Catherine, M. (2021). International Clinical Practice Guidelines for Gender Minority/Trans People: Systematic Review & Quality Assessment. How Does the Endocrine Society Fare? <em>Journal of the Endocrine Society</em>, <em>5</em>(Suppl 1), A791–A791. [DOI:<a href="https://doi.org/10.1210/jendso/bvab048.1609">10.1210/jendso/bvab048.1609</a>]</li>
|
||||
<li>Bourns, A. (2019). <em>Guidelines for Gender-Affirming Primary Care with Trans and Non-Binary Patients, 4th Edition.</em> Toronto: Rainbow Health Ontario/Sherbourne Health. [<a href="https://www.rainbowhealthontario.ca/product/4th-edition-sherbournes-guidelines-for-gender-affirming-primary-care-with-trans-and-non-binary-patients/">URL</a>] [<a href="https://www.rainbowhealthontario.ca/wp-content/uploads/woocommerce_uploads/2019/12/Guidelines-FINAL-4TH-EDITION-n7ozcr.pdf">PDF</a>]</li>
|
||||
<li>Callen-Lorde Community Health Center. (2018). <em>Protocols for the Provision of Hormone Therapy</em>. New York City: Callen-Lorde Community Health Center. [<a href="https://callen-lorde.org/transhealth/">URL</a>] [<a href="https://web.archive.org/web/20221228055728if_/https://callen-lorde.org/graphics/2018/04/Callen-Lorde-TGNC-Hormone-Therapy-Protocols.pdf">PDF</a>]</li>
|
||||
<li>Carroll, R., Nicholls, R., Carroll, R. W., Bullock, J., Reid, D., Shields, J., Johnson, R., Oliphant, J., McElrea, E., Whitfield, P., & Veale, J. (2023). <em>Primary Care Gender Affirming Hormone Therapy Initiation Guidelines: Aotearoa New Zealand Guidelines for Commencing GAHT for Adults in Primary Care.</em> Otago: University of Otago/PATHA. [<a href="https://patha.nz/Guidelines#:~:text=Primary%20Care%20Gender%20Affirming%20Hormone%20Therapy%20Initiation%20Guidelines%20(2023%20%2D%20Aotearoa%20New%20Zealand)">URL 1</a>] [<a href="https://blogs.otago.ac.nz/rainbow/">URL 2</a>] [<a href="https://patha.nz/resources/Documents/Primary-Care-GAHT-Guidelines_Web_29-Mar.pdf">PDF 1</a>] [<a href="https://blogs.otago.ac.nz/rainbow/files/2023/03/Primary-Care-GAHT-Guidelines_Web_29-Mar.pdf">PDF 2</a>]</li>
|
||||
<li>Cheung, A. S., Wynne, K., Erasmus, J., Murray, S., & Zajac, J. D. (2019). Position Statement on the Hormonal Management of Adult Transgender and Gender Diverse Individuals. <em>Medical Journal of Australia</em>, <em>211</em>(3), 127–133. [DOI:<a href="https://doi.org/10.5694/mja2.50259">10.5694/mja2.50259</a>]</li>
|
||||
<li>Coleman, E., Bockting, W., Botzer, M., Cohen-Kettenis, P., DeCuypere, G., Feldman, J., Fraser, L., Green, J., Knudson, G., Meyer, W. J., Monstrey, S., Adler, R. K., Brown, G. R., Devor, A. H., Ehrbar, R., Ettner, R., Eyler, E., Garofalo, R., Karasic, D. H., … & Zucker, K. (2012). [World Professional Association for Transgender Health (WPATH)] Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7. <em>International Journal of Transgenderism</em>, <em>13</em>(4), 165–232. [DOI:<a href="https://doi.org/10.1080/15532739.2011.700873">10.1080/15532739.2011.700873</a>] [<a href="https://www.wpath.org/publications/soc">URL</a>] [<a href="https://www.wpath.org/media/cms/Documents/SOC%20v7/SOC%20V7_English2012.pdf">PDF</a>]</li>
|
||||
<li>Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M., Green, J., Hancock, A. B., Johnson, T. W., Karasic, D. H., Knudson, G. A., Leibowitz, S. F., Meyer-Bahlburg, H. F., Monstrey, S. J., Motmans, J., Nahata, L., … & Arcelus, J. (2022). [World Professional Association for Transgender Health (WPATH)] Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. <em>International Journal of Transgender Health</em>, <em>23</em>(Suppl 1), S1–S259. [DOI:<a href="https://doi.org/10.1080/26895269.2022.2100644">10.1080/26895269.2022.2100644</a>] [<a href="https://www.wpath.org/publications/soc">URL</a>] [<a href="https://www.tandfonline.com/doi/pdf/10.1080/26895269.2022.2100644">PDF</a>]</li>
|
||||
|
|
@ -2918,7 +2929,7 @@ Using the term desistence in this way does not imply anything about the identity
|
|||
<li>Wilczynski, C., & Emanuele, M. A. (2014). Treating a transgender patient: overview of the guidelines. <em>Postgraduate Medicine</em>, <em>126</em>(7), 121–128. [DOI:<a href="https://doi.org/10.3810/pgm.2014.11.2840">10.3810/pgm.2014.11.2840</a>]</li>
|
||||
<li>Wylie, K., Barrett, J., Besser, M., Bouman, W. P., Bridgman, M., Clayton, A., Green, R., Hamilton, M., Hines, M., Ivbijaro, G., Khoosal, D., Lawrence, A., Lenihan, P., Loewenthal, D., Ralph, D., Reed, T., Stevens, J., Terry, T., Thom, B., Thornton, J., Walsh, D., & Ward, D. (2014). Good Practice Guidelines for the Assessment and Treatment of Adults with Gender Dysphoria. <em>Sexual and Relationship Therapy</em>, <em>29</em>(2), 154–214. [DOI:<a href="https://doi.org/10.1080/14681994.2014.883353">10.1080/14681994.2014.883353</a>]</li>
|
||||
<li>Ziegler, E., Carroll, B., & Charnish, E. (2021). Review and Analysis of International Transgender Adult Primary Care Guidelines. <em>Transgender Health</em>, <em>6</em>(3), 139–147. [DOI:<a href="https://doi.org/10.1089/trgh.2020.0043">10.1089/trgh.2020.0043</a>]</li>
|
||||
</ul>]]></content><author><name>{"first_name"=>"Aly", "last_name"=>"W.", "author-link"=>"/about/#aly", "articles-link"=>"/articles-by-author/aly/"}</name></author><category term="github" /><category term="workspace" /><summary type="html"><![CDATA[Clinical Guidelines with Information on Transfeminine Hormone Therapy By Aly | First published November 20, 2020 | Last modified June 26, 2024]]></summary></entry><entry><title type="html">Spironolactone and Claims About Increased Visceral Fat in Transfeminine People</title><link href="https://transfemscience.org/articles/spiro-visceral-fat/" rel="alternate" type="text/html" title="Spironolactone and Claims About Increased Visceral Fat in Transfeminine People" /><published>2020-10-25T09:56:15-07:00</published><updated>2022-10-02T00:00:00-07:00</updated><id>https://transfemscience.org/articles/spiro-visceral-fat</id><content type="html" xml:base="https://transfemscience.org/articles/spiro-visceral-fat/"><![CDATA[<h1 id="spironolactone-and-claims-about-increased-visceral-fat-in-transfeminine-people">Spironolactone and Claims About Increased Visceral Fat in Transfeminine People</h1>
|
||||
</ul>]]></content><author><name>{"first_name"=>"Aly", "last_name"=>"W.", "author-link"=>"/about/#aly", "articles-link"=>"/articles-by-author/aly/"}</name></author><category term="github" /><category term="workspace" /><summary type="html"><![CDATA[Clinical Guidelines with Information on Transfeminine Hormone Therapy By Aly | First published November 20, 2020 | Last modified November 17, 2024]]></summary></entry><entry><title type="html">Spironolactone and Claims About Increased Visceral Fat in Transfeminine People</title><link href="https://transfemscience.org/articles/spiro-visceral-fat/" rel="alternate" type="text/html" title="Spironolactone and Claims About Increased Visceral Fat in Transfeminine People" /><published>2020-10-25T09:56:15-07:00</published><updated>2022-10-02T00:00:00-07:00</updated><id>https://transfemscience.org/articles/spiro-visceral-fat</id><content type="html" xml:base="https://transfemscience.org/articles/spiro-visceral-fat/"><![CDATA[<h1 id="spironolactone-and-claims-about-increased-visceral-fat-in-transfeminine-people">Spironolactone and Claims About Increased Visceral Fat in Transfeminine People</h1>
|
||||
|
||||
<!-- Supports up to four authors per article currently (author, author2, author3, author4) -->
|
||||
|
||||
|
|
|
|||
File diff suppressed because one or more lines are too long
Loading…
Add table
Reference in a new issue